Analysis of Circulating Cell-free DNA Identifies Multi-clonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors.

Matti Annala

doi:10.1158/2159-8290.CD-17-0146

Analysis of Circulating Cell-free DNA Identifies Multi-clonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors.

Matti Annala

Research output: Contribution to journal › Article › Scientific › peer-review

249 Citations (Scopus)

Original language	English
Pages (from-to)	999-1005
Journal	Cancer Discovery
Volume	7
Issue number	9
DOIs	https://doi.org/10.1158/2159-8290.CD-17-0146
Publication status	Published - 2017
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publication forum classification

Publication forum level 1

Access to Document

10.1158/2159-8290.CD-17-0146

Cite this

@article{2a68408d6c4e47ffbb977802d3cf585d,

title = "Analysis of Circulating Cell-free DNA Identifies Multi-clonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors.",

author = "Matti Annala",

year = "2017",

doi = "10.1158/2159-8290.CD-17-0146",

language = "English",

volume = "7",

pages = "999--1005",

journal = "Cancer Discovery",

issn = "2159-8274",

publisher = "American Association for Cancer Research Inc.",

number = "9",

}

TY - JOUR

T1 - Analysis of Circulating Cell-free DNA Identifies Multi-clonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors.

AU - Annala, Matti

PY - 2017

Y1 - 2017

U2 - 10.1158/2159-8290.CD-17-0146

DO - 10.1158/2159-8290.CD-17-0146

M3 - Article

SN - 2159-8274

VL - 7

SP - 999

EP - 1005

JO - Cancer Discovery

JF - Cancer Discovery

IS - 9

ER -